Suspicious ultrasound and clinicopathological features of papillary thyroid carcinoma predict the status of TERT promoter-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Suspicious ultrasound and clinicopathological features of papillary thyroid carcinoma predict the status of TERT promoter

Published:2020-02-05 Issue:2 Volume:68 Page:349-357
ISSN:1355-008X
Container-title:Endocrine
language:en
Short-container-title:Endocrine

Author:

Shi Hui,Guo Le-Hang,Zhang Yi-Feng,Fu Hui-Jun,Zheng Jia-Yi,Wang Han-Xiang,Zhao Chong-Ke,Xu Hui-Xiong

Funder

the National Natural Science Foundation of China

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

http://link.springer.com/content/pdf/10.1007/s12020-020-02214-7.pdf

Reference47 articles.

1. H.J. Tae, D.J. Lim, K.H. Baek, W.C. Park, Y.S. Lee, J.E. Choi, J.M. Lee, M.I. Kang, B.Y. Cha, H.Y. Son, K.W. Lee, S.K. Kang, Diagnostic value of ultrasonography to distinguish between benign and malignant lesions in the management of thyroid nodules. Thyroid 17(5), 461–466 (2007). https://doi.org/10.1089/thy.2006.0337

2. Y. Ito, A. Miyauchi, M. Kihara, M. Fukushima, T. Higashiyama, A. Miya, Overall survival of papillary thyroid carcinoma patients: a single-institution long-term follow-up of 5897 patients. World J. Surg. 42(3), 615–622 (2018). https://doi.org/10.1007/s00268-018-4479-z

3. M.J. Schlumberger, Papillary and follicular thyroid carcinoma. N. Engl. J. Med. 338(5), 297–306 (1998). https://doi.org/10.1056/nejm199801293380506

4. R. Liu, J. Bishop, G. Zhu, T. Zhang, P.W. Ladenson, M. Xing, Mortality risk stratification by combining BRAF V600E and TERT promoter mutations in papillary thyroid cancer: genetic duet of BRAF and TERT promoter mutations in thyroid cancer mortality. JAMA Oncol. 3(2), 202–208 (2017). https://doi.org/10.1001/jamaoncol.2016.3288

5. T.H. Kim, C.S. Ki, H.S. Kim, K. Kim, J.H. Choe, J.H. Kim, J.S. Kim, Y.L. Oh, S.Y. Hahn, J.H. Shin, H.W. Jang, S.W. Kim, J.H. Chung, Refining dynamic risk stratification and prognostic groups for differentiated thyroid cancer with TERt promoter mutations. J. Clin. Endocrinol. Metab. 102(5), 1757–1764 (2017). https://doi.org/10.1210/jc.2016-3434

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical features combined with ultrasound characteristics to predict TERT promoter mutations in papillary thyroid carcinoma: a single-center study over the past 5 years;Frontiers in Endocrinology;2024-03-18

2. Association of Ultrasonography Features of Follicular Thyroid Carcinoma With Tumor Invasiveness and Prognosis Based on WHO Classification and TERT Promoter Mutation;Korean Journal of Radiology;2024

3. Ultrasound and clinicopathological characteristics of papillary thyroid carcinoma predict the coexistence of TERT promoter and BRAFV600E mutations;2023-10-10

4. Significance of telomerase reverse-transcriptase promoter mutations in differentiated thyroid cancer;Formosan Journal of Surgery;2021

5. Telomerase reverse transcriptase promoter mutations in thyroid carcinomas: implications in precision oncology—a narrative review;Annals of Translational Medicine;2020-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3